Data from A Compendium of Syngeneic, Transplantable Pediatric High-Grade Glioma Models Reveals Subtype-Specific Therapeutic Vulnerabilities

Abstract

<div>Abstract<p>Pediatric high-grade gliomas (pHGG) are lethal, incurable brain tumors frequently driven by clonal mutations in histone genes. They often harbor a range of additional genetic alterations that correlate with different ages, anatomic locations, and tumor subtypes. We developed models representing 16 pHGG subtypes driven by different combinations of alterations targeted to specific brain regions. Tumors developed with varying latencies and cell lines derived from these models engrafted in syngeneic, immunocompetent mice with high penetrance. Targeted drug screening revealed unexpected selective vulnerabilities—H3.3<sup>G34R</sup>/PDGFRA<sup>C235Y</sup> to FGFR inhibition, H3.3<sup>K27M</sup>/PDGFRA<sup>WT</sup> to PDGFRA inhibition, and H3.3<sup>K27M</sup>/PDGFRA<sup>WT</sup> and H3.3<sup>K27M</sup>/PPM1D<sup>ΔC</sup>/PIK3CA<sup>E545K</sup> to combined inhibition of MEK and PIK3CA. Moreover, H3.3<sup>K27M</sup> tumors with PIK3CA, NF1, and FGFR1 mutations were more invasive and harbored distinct additional phenotypes, such as exophytic spread, cranial nerve invasion, and spinal dissemination. Collectively, these models reveal that different partner alterations produce distinct effects on pHGG cellular composition, latency, invasiveness, and treatment sensitivity.</p>Significance:<p>Histone-mutant pediatric gliomas are a highly heterogeneous tumor entity. Different histone mutations correlate with different ages of onset, survival outcomes, brain regions, and partner alterations. We have developed models of histone-mutant gliomas that reflect this anatomic and genetic heterogeneity and provide evidence of subtype-specific biology and therapeutic targeting.</p><p><i><a href="https://aacrjournals.org/cancerdiscovery/article/doi/10.1158/2159-8290.CD-23-0495" target="_blank">See related commentary by Lubanszky and Hawkins, p. 1516.</a></i></p><p><i><a href="https://aacrjournals.org/cancerdiscovery/article/doi/10.1158/2159-8290.CD-13-7-ITI" target="_blank">This article is highlighted in the In This Issue feature, p. 1501</a></i></p></div>